Literature DB >> 16942862

Differential activation of the PI 3-kinase effectors AKT/PKB and p70 S6 kinase by compound 48/80 is mediated by PKCalpha.

Richard D Byrne1, Erika Rosivatz, Maddy Parsons, Banafshé Larijani, Peter J Parker, Tony Ng, Rudiger Woscholski.   

Abstract

The secretagogue compound 48/80 (c48/80) is a well known activator of calcium mediated processes and PKCs, and is a potent inducer of mast cell degranulation. As the latter process is a phosphoinositide 3-kinase (PI 3-kinase) mediated event, we wished to address whether or not c48/80 was an activator of PI 3-kinases. The data presented here reveal that c48/80 is an effective activator of PI 3-kinases as judged by the increased phosphorylation of PKB and p70(S6K) in fibroblasts in a PI 3-kinase dependent fashion. Compound 48/80 effectively translocates PKB to the plasma membrane and induces phosphorylation at serine 473 (S473), detected by fluorescence imaging of fixed cells. At higher concentrations the secretagogue is inhibitory towards PKB phosphorylation on S473. Conversely, p70(S6K) phosphorylation on T389 is unaffected at high doses. We provide evidence that the differential effect on the two PI 3-kinase effectors is due to activation of PKCalpha by c48/80, itself a PI 3-kinase dependent process. We conclude that compound 48/80 is an effective activator of PI 3-kinase dependent pathways, leading to the activation of effectors including PKB/Akt, p70(S6K) and PKCalpha. The latter is only activated by higher doses of c48/80 resulting in an inhibition of the c48/80 induced PKB phosphorylation, thus explaining the observed biphasic activation profile for PKB in response to this secretagogue.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16942862     DOI: 10.1016/j.cellsig.2006.07.004

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  6 in total

Review 1.  Regulation of mast cell responses in health and disease.

Authors:  Alasdair M Gilfillan; Michael A Beaven
Journal:  Crit Rev Immunol       Date:  2011       Impact factor: 2.214

2.  PKC-beta1 mediates glucose-induced Akt activation and TGF-beta1 upregulation in mesangial cells.

Authors:  Dongcheng Wu; Fangfang Peng; Baifang Zhang; Alistair J Ingram; Darren J Kelly; Richard E Gilbert; Bo Gao; Joan C Krepinsky
Journal:  J Am Soc Nephrol       Date:  2009-02-11       Impact factor: 10.121

3.  Mast cells play no role in the pathogenesis of postoperative ileus induced by intestinal manipulation.

Authors:  Pedro J Gomez-Pinilla; Giovanna Farro; Martina Di Giovangiulio; Nathalie Stakenborg; Andrea Némethova; Annick de Vries; Adrian Liston; Thorsten B Feyerabend; Hans-Reimer Rodewald; Hans-Reimwer Rodewald; Guy E Boeckxstaens; Gianluca Matteoli
Journal:  PLoS One       Date:  2014-01-09       Impact factor: 3.240

4.  Structural analyses of the Slm1-PH domain demonstrate ligand binding in the non-canonical site.

Authors:  Kanchan Anand; Kenji Maeda; Anne-Claude Gavin
Journal:  PLoS One       Date:  2012-05-04       Impact factor: 3.240

5.  Impaired nuclear Nrf2 translocation undermines the oxidative stress response in Friedreich ataxia.

Authors:  Vincent Paupe; Emmanuel P Dassa; Sergio Goncalves; Françoise Auchère; Maria Lönn; Arne Holmgren; Pierre Rustin
Journal:  PLoS One       Date:  2009-01-22       Impact factor: 3.240

6.  Angiopoietin1 inhibits mast cell activation and protects against anaphylaxis.

Authors:  Jun-Hua Yao; Ming Cui; Meng-Tao Li; Yi-Nan Liu; Qi-Hua He; Jun-Jun Xiao; Yun Bai
Journal:  PLoS One       Date:  2014-02-19       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.